跳至主要内容
临床试验/NCT01874652
NCT01874652已完成2 期

Assessment of Safety & Efficacy of Light Weight Breast Implant

Bnai Zion Medical Center1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2013年12月最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
50
试验地点
1
主要终点
No reoperation

研究概览

简要总结

The purpose of this study is to evaluate safety and effectiveness of Light Weight Breast Implant (LWBI) in breast augmentation.

详细描述

This is a Single-center. The purpose of the study is to evaluate safety and effectiveness of LWBI in breast augmentation.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Genetic women at ages 18 to 65 seeking breast enlargement
  • Signed informed consent
  • Agreement to complete all required follow up visits
  • A medically acceptable candidate
  • Sufficient breast tissue for proper implant coverage (≥20 mm by pinch test)

排除标准

  • Patients with active infection anywhere in their body
  • Women who are currently pregnant or nursing
  • Insufficient tissue covering in the prospective area of implantation (e.g. after preceding breast reduction), radiation damage or reduced vascularization
  • Abscesses, malignant tumors(cancer or recurrent metastases), advanced fibrocystic diseases
  • Patients with a history of psychiatric treatment
  • Patients that been implanted with any silicone implant (e.g. silicone artificial joints, facial implants)
  • Expected allergies or extraordinary immune response to implants
  • Wound healing impairments or heavy burn scars
  • Existing costal injuries
  • The Patient Participated in an investigational trial within 30 days of enrollment

研究组 & 干预措施

Light Weight Breast Implants

Experimental

Assessment of Safety and Efficacy of Light Weight Breast Implant

干预措施: Light Weight Breast Implants (Device)

结局指标

主要结局

No reoperation

时间窗: during 6 months follow up period

次要结局

  • Duration for all adverse events (AEs) on per patient and per implant basis will be recorded and analyzed.(6 month)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验